The local lymph node assay: a viable alternative to currently accepted skin sensitization tests

Area of Science:

• Toxicology
• Dermatology
• Chemical Safety

Background:

• Accurate identification of skin sensitizing chemicals is crucial for risk management.
• Traditional methods like guinea pig assays (maximization, Buehler tests) are established but have limitations.
• Regulatory bodies like the OECD and EU currently rely on these traditional assays.

Purpose of the Study:

• To review the validation status and benefits of the local lymph node assay (LLNA) for skin sensitization testing.
• To compare the LLNA with traditional guinea pig methods and human data.
• To advocate for the formal adoption of the LLNA by regulatory agencies.

Main Methods:

• Review of validation studies for the local lymph node assay (LLNA).
• Comparison of LLNA results with historical guinea pig test data.
• Analysis of LLNA performance against human data for skin sensitization.
• Assessment of practical advantages including objectivity, time, cost, and animal welfare.

Main Results:

• The LLNA has undergone extensive validation through five interlaboratory assessments.
• The LLNA demonstrates strong agreement with established guinea pig tests.
• LLNA results correlate well with human data on skin sensitization.
• The LLNA offers significant improvements in objectivity, efficiency, and cost-effectiveness.
• The method provides substantial animal welfare benefits compared to traditional assays.

Conclusions:

• The local lymph node assay (LLNA) is a scientifically validated and reliable method for assessing skin sensitization potential.
• The LLNA presents clear advantages in terms of efficiency, cost, and animal welfare.
• Formal adoption of the LLNA by the OECD (Guideline 406) and acceptance by the EU and US EPA are recommended.
• The LLNA is suitable for regulatory classification of chemical skin sensitizers.